Literature DB >> 3977643

Visual evoked potentials in pseudotumor cerebri.

P S Sørensen, W Trojaborg, F Gjerris, B Krogsaa.   

Abstract

Pattern reversal visual evoked potentials in 13 patients with pseudotumor cerebri were significantly delayed (99 +/- 7.3 ms [mean +/- SD]) compared with the findings in 20 normal subjects (94 +/- 2.7 ms), although only four patients had latencies outside the normal range. There was, however, a significant correlation between the intracranial pressure and the latency of visual evoked potentials. After medical treatment of the intracranial hypertension, visual evoked potential latencies decreased in patients who recovered and in whom the papilledema disappeared. In one patient with progressive visual failure, the visual evoked potentials were abnormal before disturbances of visual fields and visual acuity were evident. Repeated examinations of visual evoked potentials might be of value in patients with pseudotumor cerebri to ensure neurosurgical intervention in due time to prevent visual loss in patients with impending optic nerve atrophy.

Entities:  

Mesh:

Year:  1985        PMID: 3977643     DOI: 10.1001/archneur.1985.04060020064017

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  The Photopic Negative Response in Idiopathic Intracranial Hypertension.

Authors:  Heather E Moss; Jason C Park; J Jason McAnany
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

2.  Objective Measures of Visual Function in Papilledema.

Authors:  Heather E Moss
Journal:  Adv Ophthalmol Optom       Date:  2016-08

Review 3.  Big Data Research in Neuro-Ophthalmology: Promises and Pitfalls.

Authors:  Heather E Moss; Charlotte E Joslin; Daniel S Rubin; Steven Roth
Journal:  J Neuroophthalmol       Date:  2019-12       Impact factor: 3.042

Review 4.  Clinical electrophysiology of the optic nerve and retinal ganglion cells.

Authors:  Oliver R Marmoy; Suresh Viswanathan
Journal:  Eye (Lond)       Date:  2021-06-11       Impact factor: 3.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.